These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 37814058)
1. Insulin resistance is a cardiovascular risk factor in hypertensive adults without type 2 diabetes mellitus. Garcia-Carretero R; Vazquez-Gomez O; Gil-Prieto R; Gil-de-Miguel A Wien Klin Wochenschr; 2024 Feb; 136(3-4):101-109. PubMed ID: 37814058 [TBL] [Abstract][Full Text] [Related]
2. HOMA-IR as a predictor of Health Outcomes in Patients with Metabolic Risk Factors: A Systematic Review and Meta-analysis. González-González JG; Violante-Cumpa JR; Zambrano-Lucio M; Burciaga-Jimenez E; Castillo-Morales PL; Garcia-Campa M; Solis RC; González-Colmenero AD; Rodríguez-Gutiérrez R High Blood Press Cardiovasc Prev; 2022 Nov; 29(6):547-564. PubMed ID: 36181637 [TBL] [Abstract][Full Text] [Related]
3. Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular disease in Japanese elderly with type 2 diabetes mellitus. Sakurai T; Iimuro S; Araki A; Umegaki H; Ohashi Y; Yokono K; Ito H Gerontology; 2010; 56(2):141-9. PubMed ID: 19828932 [TBL] [Abstract][Full Text] [Related]
4. Prediction of Insulin Resistance with Anthropometric and Clinical Laboratory Measures in Nondiabetic Teenagers. Choi YS; Klaric JS; Beltran TH Metab Syndr Relat Disord; 2019 Feb; 17(1):37-45. PubMed ID: 30394863 [TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and risk of incident heart failure in non-diabetic patients with established cardiovascular disease. Burger PM; Koudstaal S; Dorresteijn JAN; Savarese G; van der Meer MG; de Borst GJ; Mosterd A; Visseren FLJ; Int J Cardiol; 2023 May; 379():66-75. PubMed ID: 36907452 [TBL] [Abstract][Full Text] [Related]
6. Associations of leptin and adiponectin with incident type 2 diabetes and interactions among African Americans: the Jackson heart study. Bidulescu A; Dinh PC; Sarwary S; Forsyth E; Luetke MC; King DB; Liu J; Davis SK; Correa A BMC Endocr Disord; 2020 Mar; 20(1):31. PubMed ID: 32131811 [TBL] [Abstract][Full Text] [Related]
7. Presence of hypertension modifies the impact of insulin resistance on incident cardiovascular disease in a Middle Eastern population: the Tehran Lipid and Glucose Study. Ghoreishian H; Tohidi M; Derakhshan A; Hajsheikholeslami F; Azizi F; Kazempour-Ardebili S; Hadaegh F Diabet Med; 2015 Oct; 32(10):1311-8. PubMed ID: 25711172 [TBL] [Abstract][Full Text] [Related]
8. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW Diabetes; 2005 Nov; 54(11):3252-7. PubMed ID: 16249452 [TBL] [Abstract][Full Text] [Related]
9. Association Between Insulin Resistance and Cardiovascular Disease Risk Varies According to Glucose Tolerance Status: A Nationwide Prospective Cohort Study. Wang T; Li M; Zeng T; Hu R; Xu Y; Xu M; Zhao Z; Chen Y; Wang S; Lin H; Yu X; Chen G; Su Q; Mu Y; Chen L; Tang X; Yan L; Qin G; Wan Q; Gao Z; Wang G; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Li Q; Ye Z; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Deng H; Zhao J; Shi L; Ning G; Bi Y; Wang W; Lu J Diabetes Care; 2022 Aug; 45(8):1863-1872. PubMed ID: 35700159 [TBL] [Abstract][Full Text] [Related]
10. High Prevalence of Vitamin D Deficiency and Correlation of Serum Vitamin D with Cardiovascular Risk in Patients with Metabolic Syndrome. Alkhatatbeh MJ; Abdul-Razzak KK; Khasawneh LQ; Saadeh NA Metab Syndr Relat Disord; 2017 Jun; 15(5):213-219. PubMed ID: 28346853 [TBL] [Abstract][Full Text] [Related]
11. Insulin resistance and incident peripheral artery disease in the Cardiovascular Health Study. Britton KA; Mukamal KJ; Ix JH; Siscovick DS; Newman AB; de Boer IH; Thacker EL; Biggs ML; Gaziano JM; Djoussé L Vasc Med; 2012 Apr; 17(2):85-93. PubMed ID: 22402937 [TBL] [Abstract][Full Text] [Related]
12. The association between insulin sensitivity indices, ECG findings and mortality: a 40-year cohort study. Moshkovits Y; Rott D; Chetrit A; Dankner R Cardiovasc Diabetol; 2021 May; 20(1):97. PubMed ID: 33957929 [TBL] [Abstract][Full Text] [Related]
14. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease. Fragoso A; Mendes F; Silva AP; Neves PL J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409 [TBL] [Abstract][Full Text] [Related]
15. Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver. Sung KC; Lee MY; Kim YH; Huh JH; Kim JY; Wild SH; Byrne CD Atherosclerosis; 2018 Aug; 275():50-57. PubMed ID: 29860108 [TBL] [Abstract][Full Text] [Related]
16. Healthy Chilean Adolescents with HOMA-IR ≥ 2.6 Have Increased Cardiometabolic Risk: Association with Genetic, Biological, and Environmental Factors. Burrows R; Correa-Burrows P; Reyes M; Blanco E; Albala C; Gahagan S J Diabetes Res; 2015; 2015():783296. PubMed ID: 26273675 [TBL] [Abstract][Full Text] [Related]
17. Insulin resistance is associated with increased cardiovascular risk in Asian Indians with normal glucose tolerance--the Chennai Urban Rural Epidemiology Study (CURES-66). Sandeep S; Gokulakrishnan K; Deepa M; Mohan V J Assoc Physicians India; 2011 Aug; 59():480-4. PubMed ID: 21887902 [TBL] [Abstract][Full Text] [Related]
18. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Bonora E; Formentini G; Calcaterra F; Lombardi S; Marini F; Zenari L; Saggiani F; Poli M; Perbellini S; Raffaelli A; Cacciatori V; Santi L; Targher G; Bonadonna R; Muggeo M Diabetes Care; 2002 Jul; 25(7):1135-41. PubMed ID: 12087010 [TBL] [Abstract][Full Text] [Related]
19. Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex. Matsubayashi Y; Fujihara K; Yamada-Harada M; Mitsuma Y; Sato T; Yaguchi Y; Osawa T; Yamamoto M; Kitazawa M; Yamada T; Kodama S; Sone H Cardiovasc Diabetol; 2022 Jun; 21(1):90. PubMed ID: 35655263 [TBL] [Abstract][Full Text] [Related]
20. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren. Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]